JCRB1091 NCE SVIIA3
Cell information
Important Notice(s)Supplements for the Serum free culture medium
Cell type:general cells (View Pricing Information)
JCRB No. | JCRB1091 | Cell Name | NCE SVIIA3 |
---|---|---|---|
Profile | SV40 transformed keratinocyte cells derived from human cervix. | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | F | Age | adult |
Identity | available | Tissue for Primary Cancer | cervix |
Case history | Metastasis | ||
Tissue Metastasized | Genetics | SV40 ori(-), teromerase positive, P75NTR positive. | |
Life Span | infinite | Crisis PDL | |
Morphology | epithelial-like | Character | SV40 transformed human keratinocyte from cervix. |
Classify | transformed | Established by | Yasumoto,S. |
Registered by | Yasumoto,S. | Regulation for Distribution | Not apllied. |
Comment | Year | 2001 | |
Medium | MCDB153 medium (0.03 mM Ca2+) with 5 ug/ml insulin, 0.5 ug/ml hydrocortisone, 10 ug/ml transferrin, 0.1 mM phosphorylethanolamine, 0.1 mM ethanolamine, 10 ng/ml EGF and 40-70 ug/ml bovine pituitary extract. | Methods for Passages | Cells are harvested with 0.1% trypsin and 0.1% EDTA. Medium change every 2 days and subculture every 10 days. |
Cell Number on Passage | 1.5 - 2.4 x 10^5 cells/sq.cm. | Race | Japanese |
CO2 Conc. | Tissue Sampling | cervix | |
Tissue Type |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:12747968 | Gene expression of telomerase related proteins in human normal oral and ectocervical epithelial cells. Fujimoto R,Kamata N,Taki M,Yokoyama K,Tomonari M,Nagayama M,Yasumoto S Oral Oncol. 2003 Jul;39(5):445-52 |
Images |
---|
LOT Information
Cell No. | JCRB1091 | Cell Name | |
---|---|---|---|
LOT No. | 11102005 | Lot Specification | distribution |
Medium | MCDB153 medium with 5 ug/ml insulin, 0.5 ug/ml hydrocortisone, 10ug/ml transferrin, 0.1mM phosphoethanolamine, 0.1 mM ethanolamine, 10 ng/ml EGF, 50 ug/ml BPE (serum-free). | Temperature | 37 C |
Cell Density at Seeding | 2.7 - 5.9 x 10^4 cells/ml | Methods for Passages | 0.025% trypsin and 0.02% EDTA. Trypsin activity was stopped with soybean trypsin inhibitor. |
Doubling Time | approx. 3 days | Cell Number in Vial (cells/1ml) | 1.1 x 10^6 |
Viability at cell freezing (%) | 54.3 | Antibiotics Used | free |
Passage Number | P22 | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), LD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | D5S818:12 D13S317:11,12 D7S820:8,11 D16S539:11,12 VWA:16,18 TH01:7 AM:X TPOX:9,12 CSF1PO:11,12 |
|
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 0.1% methylcellulose - culture medium | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |